retatrutide mechanism triple agonist glp-1 gip glucagon Retatrutide: How GLP-1/GIP/Glucagon Receptor Agonism Differs From Existing Compounds Retatrutide in Johnson County -

Epidemiology 33 , 563571 (2022)

+What researchers commonly report Researchers commonly report rapid early appetite suppression, fewer cravings, and meaningful changes in body composition over multi-week protocols

Some common side effects are: Digestive issues and nausea: Because GLP-1 slows digestion, food sitting in the stomach for longer periods of time can cause nausea or digestive discomfort Nutritional deficiencies: With appetite suppressants come less food intake, theres a risk of not getting enough of the vitamins and minerals that our bodies still need Low energy or fatigue: Some people may experience fatigue while taking GLP-1 but this effect is typically brief

TRIUMPH-1 and TRANSCEND-T2D-1 full data

You inject Thursday evening

Retatrutide in Type 2 Diabetes Recent clinical research on retatrutide, a novel triple-hormone receptor agonist, has shown promising results for people with type 2 diabetes